Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cells for Leg Ulcers in Sickle Cell Disease
NCT02619734Phase 1Unknown
- Sponsor
- Universidade Federal da Bahia
- Start
- Aug 2006
- Primary completion
- Jul 2016
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, open-label trial of autologous bone marrow-derived mononuclear cell in leg ulcer (2 arms), sponsored by Universidade Federal da Bahia. Primary endpoints: Safety of Treatment at 6 months and Change in Leg Ulcer at 1 year. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
leg ulcer
Beyond the preview
Go deeper on NCT02619734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619734.